Breaking down acronyms with the experts who work with them day in and day out
April 29, 2019

Dr. Samantha Gomez Ngamsuntikul, Associate Medical Director at BioBridge Global, was part of the team that implemented the Brothers in Arms program to bring lifesaving blood transfusions to seriously injured patients in San Antonio and South Texas. She answers the question “What is LTOWB?”

What is LTOWB?

LTOWB stands for low-titer type O-positive whole blood.

Breaking down acronyms with the experts who work with them day in and day out
April 22, 2019

Samantha Gomez Ngamsuntikul, Associate Medical Director, oversees medical procedures, regulatory compliance and clinical trials at the South Texas Blood & Tissue Center. She answers the question “What is TRALI?”

TRALI stands for transfusion-related acute lung injury. It is a rare, sometimes deadly respiratory complication that occurs within six hours after receiving a blood transfusion. Symptoms include difficulty breathing, low oxygen levels and excess fluid in the lungs. 

Breaking down acronyms with the experts who work with them day in and day out
April 15, 2019

Anand Srinivasan, Director of Innovation & BioDesign, and Jennifer Wehmeyer, Scientist II, Research & Development, help BioBridge Global and its subsidiaries by working on stem cell research projects, with the goal of getting new ideas into the cellular therapy market. They answer the question “What are MSCs?”

What are MSCs?

MSCs stands for mesenchymal stem cells or mesenchymal stromal cells. These are a type of adult stem cell which possess the ability to form/differentiate into other cells such as skin, bone, fat, cartilage, muscle, tendon and blood vessels.

April 8, 2019

Better safety measures are needed for the nation’s blood supply, said two U.S. Food & Drug Administration leaders in a recent statement on the FDA website.

FDA Commissioner Scott Gottlieb and Peter Marks, Director of the FDA Center for Biologics Evaluation and Research, advocated for technology that would kill or inactivate infectious agents in donated whole blood.

“Pathogen reduction technologies can address the infectious risk from viral and bacterial pathogens, enabling us to improve our assurance of safety and reduce the cost of testing,” the statement said.

April 2, 2019

Legally, The Blood & Tissue Center Foundation began on Aug. 19, 2002 when a charter was filed with the state of Texas.

But the origins date to Valentine’s Day, 1993, when a small group of local dignitaries and officials of the South Texas Blood & Tissue Center broke ground on a new facility for the center on Interstate 10. The date was noteworthy because the double hearts had been the organization’s logo for more than 20 years, including its time in the 1920s-era YWCA building in downtown San Antonio.

The new facility opened in 1994 with 80,000 square feet of space that included a state-of-the-art laboratory, donor collection rooms, offices and meeting spaces. It was financed in large part by a tax-exempt bond financed by USAA.